Emmes

Traditional drug development doesn’t often fit the needs of rare disease patients. With the rise of precision medicine, tailored treatments are offering new hope. Discover how personalized medicine is transforming rare disease trials and gain insights from the rare disease community on the evolving research landscape in our whitepaper “Thinking of the Individual in Rare Disease Clinical Trials”: https://lnkd.in/eRkSGyJw #PersonalisedMedicine #RareDiseaseDay2025 #RareDiseaseAdvocacy #PatientFocused #Emmes #CRO

Watch another part of Peter Ronco's interview at #SCOPE, where he shares insightful advice on scaling clinical programs for small biopharma companies, with Don Tracy, Associate Editor of Applied Clinical Trials Magazine. > Build a strong core team: Project Manager, Statistician, and MD Support. > Partner with providers who can grow with you. Watch the full interview for more expert tips! 👇 https://lnkd.in/eccSykfq #biopharma #clinicaltrials #Emmes #PeterRonco #pharmascience #BiotechPartnerships #ClinicalTrialInsights #EmmesGroup #CRO 

In part 3 of our CGT trials video series, we focus on minimizing patient burden. With intense trials and patients who've often undergone multiple treatments, it's crucial that only necessary procedures are conducted to gather the right data. As the longest-standing CGT-specialized CRO, with 125+ trials in 35 years, we understand the importance of trial design, patient recruitment, and site selection. At Emmes, we're committed to advancing medicine through clinical research for years to come. Watch the video now! #CGT #ClinicalTrials #PatientBurden #GeneTherapy #CellTherapy #ResearchAdvancement #Emmes #CRO #EmmesGroup

As the industry's longest-standing cell and gene therapy (CGT) specialized CRO, with 125+ CGT trials conducted over the past 35 years, Emmes Group knows the importance of getting trial design right. With a limited patient population, site selection and patient recruitment become critical for visibility and success. Beyond that, when FDA guidance is unavailable, the project team must carefully consider all factors to determine the best approach for answering the clinical question. We are committed to advancing clinical research and being a trusted partner in the CGT field for years to come. Watch the video to learn more! #CGT #CellAndGeneTherapy #ClinicalTrials #CRO #EmmesGroup #Innovation #TrialDesign

Emmes Group is proud to announce that we’ve achieved ISO/IEC 27001:2022 certification, the gold standard for data security! This accreditation highlights our commitment to safeguarding sensitive information and advancing secure, data-driven trials for our biotech and pharma partners. With AI and advanced analytics transforming clinical research, data security is more critical than ever. Read the full press release here: https://lnkd.in/gUkzaBPY #DataSecurity #ISO27001 #ClinicalTrials #EmmesGroup #Pharma #Biotech #AI #Innovation #ClinicalResearch #DataProtection #InformationSecurity #Certification

In an interview with ACT’s Don Tracy, Peter Ronco, Emmes CEO, shares insights from the “Choosing the Right Allies” session, highlighting the Goldilocks principle—finding a partner that’s the right size to deliver results with personalized attention. He also emphasizes transparency and collaboration for overcoming challenges in clinical trials. Interested in more insights? Watch the rest of the interview to learn how small biotechs can select the right partners for success! https://lnkd.in/efr5xCq5 #ClinicalTrials #Biopharma #SmallBiotech #Partnerships #Emmes #CRO #EmmesGroup #TransparencyInTrials #CollaborationInBiotech #BiotechIndustry #BiotechPartnerships

We are thrilled to share that Emmes leaders are co-authors on two clinical trials that were chosen as Late Breaking Oral Presentations as part of the Tandem meetings of the ASTCT and CIBMTR happening next week in Honolulu, Hawaii! These two studies (abstract #LBA-1 and #LBA-2) conducted by the NIH-funded Blood and Marrow Transplant Clinical Trials Network (BMT CTN) were reviewed as highest impact thus placing the results at the forefront of the Tandem meetings. Emmes is proud to have collaborated on these two programs as these innovative studies advance the field for patients with multiple myeloma and for patients with high-risk acute graft versus host disease. Check out the details below for more information and be sure to visit our presentation at the conference. Looking forward to connecting with everyone at #TANDEM25 Ling Bai, Laura Morrison, Erica Anderson, Jennifer Romeril, Adam Mendizabal, Jenna Cohen McGuirk #Emmes #ClinicalTrials #Tandem25 #BMTCTN #InnovativeResearch #ClinicalResearch #TandemMeetings2025 #ScientificCollaboration #ASTCT #CIBMTR

We're honored to have had our CEO, Peter Ronco, recently interviewed by Associate Editor Donald Tracy, MA! In the conversation, Peter shared valuable insights on how small #biopharma companies can navigate clinical trial partnerships, from selecting the right partners to making the most of limited resources. Want to learn more? Watch the full interview now and discover how our solutions can guide your clinical research projects to success. #ClinicalResearch #AI #BiopharmaInnovation #CRO #SuccessInResearch

We’re absolutely thrilled to announce that Emmes Group, has earned a nomination for the highly prestigious Vaccine Industry Excellence Awards in the category of Best Contract Research Organization! This recognition highlights the incredible dedication and innovative work of our entire team, and we couldn’t be more honoured to be in the running. We’ve always been driven by our passion to lead in clinical research, and this nomination represents the collective effort of so many brilliant minds here at Emmes Group. Now, it’s time to bring that vision to life – and with your help, we can take this journey to new heights! Thank you for being part of this incredible ride with us. Vote now: https://lnkd.in/e8ad9A_4 #VaccineExcellence #ClinicalResearch #VaccineInnovation #EmmesGroup #VoteForExcellence #GlobalHealth #ClinicalTrials #VaccineAwards

SCOPE is off to a great start! Stop by booth #720 to meet our team and discuss how we can enhance your clinical trials with our clinical research services and cutting edge AI solutions. #SCOPEsummit2025 #clinicaltrials